All attending UK organisations

UK companies attending as part of the official delegation

(Click here to search profiles):

UK Exhibitors
BioPartner UK:UK stand, booth #50, Barrington James (booth #77), Cancer Research Horizons (booth #58), Sekisui (booth #22), Sapio Sciences (booth #122)

UK stand (booth #50) and Regional Groups:
Almac Discovery, Almac Group, BIA, Bionow, bit.bio, Catalyst Clinical Research, CLINICAL ACCELERATOR, Cognite, Enterika, hVIVO, IDEA Regulatory, Intract Pharma, Isogenica, Leith Healthcare, Medherant, MediWales, Nevrargenics, NIHR, NOCRI, Oncimmune, Oppilotech, PrecisionLife, Research Donors, Rosemont Pharmaceuticals, Sareum, Scendea, Scottish Development International, Silence Therapeutics, Sphere Fluidics, The Institute of Cancer Research, The Science Behind.

Other UK companies associated with the delegation*:
Alan Boyd Consultants, Arecor, DLRC, Ellipses Pharma, Etcembly, Glykogen, Ingenza, Mereo BioPharma Group, Mills & Reeve, Norgine, ProImmune, SBA, Shanghai Mediclon.

UK Presenting companies:
will be listed here

All attending UK companies:
4basebio Discovery  4C Biomed, Abcam, Abzena, Accession Therapeutics, Acclime, ACCORD HEALTHCARE, Achilles Therapeutics, Actigen, Added Health, ADM, Advanced Clinical, Advanz Pharma, Aivivo, Aixial Group UK, Alan Boyd Consultants, Alantra, Alchemab Therapeutics, Almac Discovery, Almac Group, AlphaSense, Andrew Moore - Self Employed, Antibody Analytics, Antikor Biopharma, Antiverse, Apex Molecular, Apollo Therapeutics, Aptamer Group, Arc Bio Communications, ARC Regulatory, Arecor, Ascend Gene & Cell Therapies, AscendBio, Asieris Pharmaceuticals, ASKA Pharmaceutical Co,, Aspire Biosciences, Aspire Pharma, Astellas, Aston University, Astorg, Astrazeneca, Atheneum Partners, Autolus, aVaxziPen, Ayr Coastal Media, Bank of America, Barrington James, Basecamp Research, BenevolentAI, BIA, Bicycle Therapeutics, Biogen, BioPartner UK, Biosynth GmbH, Biotechgate, bitbio, BiVictriX Therapeutics, Bloomsbury Genetic Therapies, Box, Bristol-Myers Squibb Company, Bristows, Calluna Pharma, Cambrex, Canaccord Genuity, Cancer Research Horizons, CanLucent (University of Aberdeen spin out), Catalent, Catalyst Clinical Research, Causeway Sensors, CCDC, Cell and Gene Therapy Catapult, Centauri Therapeutics, CEPI (Coalition for Epidemic Preparedness Innovations), Certara, Chain Biotech, Charles River, Charles River Associates, Charm Therapeutics, Charnwood Molecular, Chromatin Bioscience, Chugai Pharma, Citeline, ClientPharma, CLINICAL ACCELERATOR, Clinigen Healthcare, Closed Loop Medicine, Cognite, Colibri Scientific, Concr, Constructive Biology, Cooley, Coulter Partners, Crescendo Biologics, CrimsonXT, Cumulus Oncology, Curileum Discovery, CV6 Therapeutics (NI), Danforth Advisors UK, DCA Design International, Dendreon Corporation, Dept for Business and Trade, Destiny Pharma, DLRC, Domainex, e -therapeutics, EBD Group, Edgecap Partners, Edinburgh Molecular Imaging, Eisai, Elanco Animal Health, Elastin Biosciences, Eli Lilly & Company, Ellipses Pharma, Enara Bio, Endpoint Clinical, Enterika, Epsilogen, ESP Diagnostics, Etcembly, Eurofins Selcia, EUROSCIENCEJOBS / EUROPHARMAJOBS (EuroJobsites ), Evaluate, Evariste, EVolution Therapeutics, Evox Therapeutics, Exploristics, Exscientia, F -Prime, F -Prime Capital, F -star, Firefinch Software, Fitabeo Therapeutics, Five Arrows, Forcefield, FUJIFILM Diosynth Biotechnologies, Fusion Antibodies, G&L Healthcare Advisors, Gentronix, GHO Capital, Gill Jennings & Every, GlobalData, Glykogen, Gowling WLG (UK), GSK, Harness Therapeutics, HealthCare Royalty, Healx, Heidrick & Struggles, Heptares Therapeutics, High Commission of Canada, Hobson Prior, Hurdle, hVIVO, Hypo-Stream, IAG, ICON, IDEA Regulatory, iiCON, Liverpool School of Tropical Medicine, Iksuda Therapeutics, Immodulon Therapeutics  Immunocore, ImmuPharma, Imophoron, Imperial College London, IN-PART, Incubate Bio, Independent Advisor, Indivior, Informa, Ingenza, Insmed, Inspiralis, Intract Pharma, Invenia Group, Invest Northern Ireland, invoX Pharma, Ipsen Pharma, IQVIA, Isogenica, Isomorphic Labs, Janssen Pharmaceutica NV, Jazz Pharmaceuticals, Johnson & Johnson Innovation, Kerna Ventures, King's College London, Kuano, Kynos Therapeutics, Labcorp, LabGenius, Leith Healthcare, Leucid Bio, Life Sciences Recruitment, LifeArc, LIfT Biosciences, Liftbiosciences, LiliumX, Livzon Pharmaceutical Group, Longaevus Technologies, Lonza Biologics, LoQus23 Therapeutics, LSX, Lumanity, Mab Designs, Macomics, Medherant, Medical Research Network, MEDICXI, MediMabBio, MediSieve, Medistrava, MediWales, MedPharm, Merck LS KGaA, Darmstadt, Germany, Mereo BioPharma Group, Merxin, MetaCell, Micron Research, MILLIPORE UK, Mills & Reeve, MindRank, Mironid, MitoRx Therapeutics, Mitsubishi Tanabe Pharma, Monograph Capital, MonumentTx, Morgan Prestwich, MSD, MultiOmic Health, Nanomerics, Nanovery, National Institute for Health and Care Research (NIHR), Neurentis, Neurocentrx, Nevrargenics, NIHR Office for Clinical Research Infrastructure (NOCRI), NK:IO, Nordic Pharma, Norgine, NRG Therapeutics, Nuclera, NW PharmaTech, OBN UK, Ochre Bio, OES, OMass Therapeutics, Omideon, Oncimmune, OncoBone Verntures, One Nucleus, ONO Pharma, Onyx Scientific, Oppilotech, Oranda Therapeutics, Orbit Discovery, Orchard Therapeutics, Ossianix, Otsuka Pharmaceuticals, Oxford Biomedica, Oxford Biotherapeutics, Oxford Drug Design, Oxford Immunotec, Oxgene, partneringONE, People, Value, Research (PVR), Peptone, Phaim Pharma, Pharma and Safety Solutions, Pharmanovia, Pharmathen UK, PharmaVentures, PharmEnable, Phetairos, pHion Therapeutics, PhoreMost, Physiomics, Pneumagen, Poolbeg Pharma, Poolbeg Pharma, Pracipio, Precision for Medicine, PrecisionLife, Premier Research, PrimeVigilance, Probatech, Proclinical Group, ProImmune, Prokarium, Protagoras Group, Purespring Therapeutics, Putnam, QPS Netherlands, Quell Therapeutics, Quotient Sciences, Raymond James, ReceptorAI, Reef Group, Rentschler ATMP, Research Donors, Riverlabs, Rosemont Pharmaceuticals, Roslin Cell Therapies, S M Discovery Group (SMDG), Sage Healthcare, Sagentia Innovation, Sai Life Sciences, Samedan, Samsung Ventures, Sania Therapeutics, Sapient Therapeutics, Sapio Sciences, Sareum, SBA, Scancell, Scendea, Schrödinger, Scius Communications, Scottish Development International, Seda Pharmaceutical Development Services, Sekisui, SGS, SGS Quay Phaema, SGS Vitrology, Shanghai Medicilon, Shionogi, Silence Therapeutics, Simbec -Orion, Simcere Pharma, SiSaf, Sitryx Therapeutics, Sixfold Bioscience, SLA, Sofinnova Partners, Sphere Fluidics, Spirea, Stifel, Sutura Therapeutics, SV Health Investors, Swarm Oncology, Sygnature Discovery, Symbiosis, Syncona Investment Management, Syneos Health, SynOx Therapeutics, TA Associates, Taylor Wessing, Technology Holdings Worldwide, Techspert, Tenshi Kaizen, The Fulford Group, The Institute of Cancer Research, The Science Behind, The University of Edinburgh, Therakind, Theramex, TidalSense, Tiziana Life Sciences, TMC Pharma, Topia Lifesciences, TriNetX, Trinova Consulting, Triton Beratungsgesellschaft GmbH, TTP, Twist Bioscience, UBS, UCB, UCL Business, UK Biocentre, Unison, Vaccitech, Valirx, Vernalis Research, Vicebio, Weatherden, WEP Clinical, William Reed Business Media, WuXi AppTec, WuXi Biologics, Zura Bio. (378)

Join them here!